Woodford Woes Drag On For Immunocore
Unrealistic Valuations Holding Private Firms Back
Once seen as the champion of biotech start-ups, Woodford’s blind faith has shackled firms to unrealistic valuations.
Once seen as the champion of biotech start-ups, Woodford’s blind faith has shackled firms to unrealistic valuations.